JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB51259

Recombinant ヒト ABL2 protein (His tag N-Terminus)

Recombinant human ABL2 protein (His tag N-Terminus)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant human ABL2 protein (His tag N-Terminus) is a Human Fragment protein, in the 38 to 1167 aa range, expressed in Baculovirus infected Sf9 cells, with >70%, suitable for FuncS.

別名を表示する

ABLL, ARG, ABL2, Tyrosine-protein kinase ABL2, Abelson murine leukemia viral oncogene homolog 2, Abelson tyrosine-protein kinase 2, Abelson-related gene protein, Tyrosine-protein kinase ARG

3 Images
Functional Studies - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)
  • FuncS

Unknown

Functional Studies - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)

The specific activity of ABL2 (ab51259) was determined to be 1050 nmol/min/mg as per activity assay protocol

SDS-PAGE - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)

Sample Purity Data.

SDS-PAGE - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant human ABL2 protein (His tag N-Terminus) (AB51259)

SDS PAGE analysis of ab51259

Key facts

精製度

>70% Densitometry

Affinity purified.

発現系

Baculovirus infected Sf9 cells

タグ

His tag N-Terminus

アプリケーション

FuncS

applications

生物活性

Yes

生物学的活性

Active

アクセッション番号

P42684

アニマルフリー

No

キャリアフリー

No

Human

バッファー組成

pH: 7 Preservative: 1.02% Imidazole Constituents: 25% Glycerol (glycerin, glycerine), 1.74% Sodium chloride, 0.82% Sodium phosphate, 0.00308% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00174% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

ab204848 (c Abl peptide) can be utilized as a substrate for assessing Kinase activity

配列情報

[{"linker":null,"sequence":"","proteinLength":"Fragment","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":1167,"aminoAcidStart":38,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P42684","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
出荷温度
Dry Ice
短期保存温度
-80°C
長期保存温度
-80°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
True

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

ABL2 also known as ARG (Abelson-related gene) is a non-receptor tyrosine kinase with a mass of approximately 120 kDa. It shares structural similarities with its relative ABL1 and is primarily localized in the cytoplasm and nucleus of cells. Expression of ABL2 occurs in various tissues including the brain where it plays significant roles in neuronal development. ABL2 functions mechanically by transferring a phosphate group from ATP to tyrosine residues on specific substrates which modulates the activity and function of these substrates.
Biological function summary

ABL2 contributes to cellular processes such as actin cytoskeleton remodeling cell migration and adhesion. This protein interacts with different binding partners through its SH2 and SH3 domains implicating it in cellular signal transduction. ABL2 has been observed to occasionally form part of complexes that regulate these processes contributing to dynamic changes in cell morphology and motility.

Pathways

ABL2 plays a significant role in the downstream signaling of receptor tyrosine kinases and integrins linking it to pathways like the PDGF and VEGF signaling pathways. ABL2 interacts with proteins such as CRK and C3G which influence cytoskeletal reorganization and cellular responses to external stimuli. These interactions highlight its role in conveying signals from the cell surface to internal signaling cascades.

ABL2 shows connections to various types of cancer including glioblastoma and chronic myeloid leukemia. Genetic alterations or dysregulation of ABL2 activity can lead to abnormal cellular proliferation and migration contributing to these malignancies. In particular the oncogenic fusion protein BCR-ABL derived from ABL1 is a well-known factor in leukemia and disruptions in ABL2 can similarly impact oncogenic signaling pathways. Research is ongoing to further understand ABL2’s involvement in tumorigenesis and its potential as a therapeutic target.

一般的な情報

機能

Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 also acts as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity).

配列の類似性

Belongs to the protein kinase superfamily. Tyr protein kinase family. ABL subfamily.

翻訳後修飾

Phosphorylated at Tyr-261 by ABL1 in response to oxidative stress. Phosphorylated by PDGFRB (By similarity).. Polyubiquitinated. Polyubiquitination of ABL2 leads to degradation.

製品プロトコール

ターゲットの情報

Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 also acts as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity).
See full target information ABL2

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com